Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELTROMBOPAG for Aplastic anaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,121 adverse event reports in the FDA FAERS database where ELTROMBOPAG was used for Aplastic anaemia.

Most Reported Side Effects for ELTROMBOPAG

Side Effect Reports % Deaths Hosp.
Platelet count decreased 968 17.7% 148 545
Death 629 11.5% 629 80
Drug ineffective 554 10.1% 86 201
Product use in unapproved indication 303 5.5% 70 69
Thrombocytopenia 262 4.8% 33 112
Off label use 255 4.7% 50 87
Headache 229 4.2% 27 125
Pyrexia 229 4.2% 45 163
Haemoglobin decreased 213 3.9% 41 117
Pneumonia 204 3.7% 86 124
Platelet count increased 186 3.4% 24 101
Haemorrhage 173 3.2% 35 80
Therapy non-responder 166 3.0% 39 42
Malaise 154 2.8% 31 116
Anaemia 146 2.7% 28 53

Other Indications for ELTROMBOPAG

Immune thrombocytopenic purpura (1,734) Immune thrombocytopenia (792) Product used for unknown indication (612) Thrombocytopenia (531) Myelodysplastic syndrome (246) Thrombocytopenic purpura (117) Platelet count decreased (57) Bone marrow failure (52) Acute myeloid leukaemia (40) Foetal exposure during pregnancy (34)

Other Drugs Used for Aplastic anaemia

CYCLOSPORINE (1,668) ELTROMBOPAG OLAMINE (1,617) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (421) EQUINE THYMOCYTE IMMUNE GLOBULIN (293) DEFERASIROX (277) THYMOCYTE IMMUNE GLOBULIN NOS (249) ROMIPLOSTIM (231) CYCLOPHOSPHAMIDE (122) METHYLPREDNISOLONE (90) TACROLIMUS (87)

Related Pages

ELTROMBOPAG Full Profile All Aplastic anaemia Drugs ELTROMBOPAG Demographics ELTROMBOPAG Timeline